AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

IperionX Limited

$18.13 -$21.78 (-54.57%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$18.67
Day Range
$17.68$18.53
Year Range
$17.4$61.45
Market Cap
608.44M
AVG Volume
290.83K
Trailing/Forward PE
-10.47/-
PEG ratio
0.02
Dividend Yield
-
Next Earnings Date
2026-09-23
Primary Exchange
NASDAQUS
Revenue (USD)
00.250.50.75121 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q20
25 Q40
25 Q20
24 Q40
24 Q20
23 Q40
23 Q20
22 Q40
22 Q20
21 Q40
Net Income (USD)
-40M-30M-20M-10M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-34.83M
25 Q4-35.33M
25 Q2-16.24K
24 Q4-5.67K
24 Q2-5.25K
23 Q4-4.34K
23 Q2-4.38K
22 Q4-5.48K
22 Q2-5.28K
21 Q4-13.27M
Operating Income (USD)
-40M-30M-20M-10M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-36.67M
25 Q4-18.74M
25 Q2-20.46M
24 Q4-6.25K
24 Q2-10.2M
23 Q4-4.49K
23 Q2-4.34K
22 Q4-5.59K
22 Q2-5.35K
21 Q4-8.12M
EBITDA (USD)
-40M-30M-20M-10M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-34.72M
25 Q4-37.77M
25 Q2-20.16K
24 Q4-6.22K
24 Q2-5.01K
23 Q4-4.48K
23 Q2-4.33K
22 Q4-5.59K
22 Q2-5.35K
21 Q4-8.82M
Cash Flows (USD)
-40M-30M-20M-10M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-14.22M
25 Q4-39.39M
25 Q2-16.23K
24 Q4-1.08M
24 Q2-4.76M
23 Q4-385.14K
23 Q2-530.79K
22 Q4-4.28M
22 Q2-3.2M
21 Q4-3.62M
EPS (USD)
-15-10-5021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-10.4
25 Q4-0
25 Q2-0.06
24 Q4-0.05
24 Q2-5
23 Q4-0
23 Q2-0
22 Q4-0
22 Q2-0
21 Q4-0.75
Expenses (USD)
020M40M60MR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q240.06M
25 Q456.85M
25 Q225.02K
24 Q41.08M
24 Q21M
23 Q4385.49K
23 Q2531.34K
22 Q41.17M
22 Q2252.78K
21 Q48.35M
Cash & Debt (USD)
020M40M60M80MCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q265.83M
25 Q454.81M
25 Q277.13M
24 Q433.16M
24 Q217.33M
23 Q411.94M
23 Q211.44M
22 Q45.67M
22 Q214.26M
21 Q41.7M
Debt ratios
010002000300021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Debt ratios by quarter
PeriodDebt ratios
26 Q20.85
25 Q41.35
25 Q22033.1
24 Q41579.78
24 Q2806.01
23 Q4555.18
23 Q21.16
22 Q40.58
22 Q21.55
21 Q40.14
Margins
0%20%40%60%19 Q420 Q4
IPX Margins by quarter
PeriodMargins
20 Q450%
19 Q447.37%
Return on Capital
-800%-600%-400%-200%0%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Return on Capital by quarter
PeriodReturn on Capital
26 Q2-32.19%
25 Q4-38.22%
25 Q2-0.02%
24 Q4-0.01%
24 Q2-0.02%
23 Q4-0.02%
23 Q2-0.03%
22 Q4-0.07%
22 Q2-0.04%
21 Q4-754.12%
Shares Outstanding
010M20M30M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Shares Outstanding by quarter
PeriodShares Outstanding
26 Q23.36M
25 Q429.46M
25 Q227.06M
24 Q422.58M
24 Q220.99M
23 Q419.02M
23 Q214.59M
22 Q413.7M
22 Q213.2M
21 Q413.2M
Book Value Per Share (USD)
01020304021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q232.17
25 Q43.14
25 Q23.9
24 Q42.27
24 Q21.44
23 Q41.08
23 Q21.05
22 Q40.54
22 Q21.14
21 Q40.13
Total Assets (USD)
050M100M150M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IPX Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q2129.16M
25 Q4105.03M
25 Q2115.83M
24 Q455.44M
24 Q234.04M
23 Q422.8M
23 Q218M
22 Q49.91M
22 Q216.16M
21 Q42.79M
Employee Count
0204060802022202320242025
IPX Employee Count by quarter
PeriodEmployee Count
202570
202448
202330
202228
Free Cash Flow Yield
-100%-75%-50%-25%0%med -1.6%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IPX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-89.71%
Sep 26-87.12%
Sep 26-74.78%
Aug 26-77.41%
Aug 26-72.29%
Aug 26-69.01%
Aug 26-64.83%
Jul 26-78.38%
Jul 26-75.44%
Jul 26-70.9%
Jul 26-64.98%
Jul 26-56.51%
Jun 26-61.38%
Jun 26-52.42%
Jun 26-45.12%
Jun 26-46.18%
May 26-39.32%
May 26-43.23%
May 26-44.94%
May 26-39.47%
May 26-48.61%
Apr 26-55.27%
Apr 26-49.47%
Apr 26-51%
Apr 26-59.73%
Mar 26-70.26%
Mar 26-69.84%
Mar 26-46.64%
Mar 26-34.74%
Feb 26-33.45%
Feb 26-38.51%
Feb 26-39.91%
Feb 26-37.74%
Jan 26-32.57%
Jan 26-2.56%
Jan 26-3.28%
Jan 26-3.51%
Jan 26-3.85%
Dec 25-4.16%
Dec 25-4.64%
Dec 25-4.31%
Dec 25-4.52%
Nov 25-4.54%
Nov 25-5.28%
Nov 25-4.5%
Nov 25-4.21%
Oct 25-3.5%
Oct 25-3.09%
Oct 25-3.01%
Oct 25-0.42%
Oct 25-0.42%
Sep 25-0.45%
Sep 25-0.55%
Sep 25-0.52%
Sep 25-0.48%
Aug 25-0.52%
Aug 25-0.55%
Aug 25-0.55%
Aug 25-0.61%
Aug 25-0.61%
Jul 25-0.57%
Jul 25-0.68%
Jul 25-0.7%
Jul 25-0.77%
Jun 25-0.75%
Jun 25-0.84%
Jun 25-0.89%
Jun 25-0.82%
May 25-0.95%
May 25-0.98%
May 25-1.09%
May 25-1.01%
May 25-1.05%
Apr 25-1.09%
Apr 25-1.17%
Apr 25-1.58%
Apr 25-1.63%
Mar 25-1.28%
Mar 25-1.14%
Mar 25-1.11%
Mar 25-1.12%
Feb 25-0.97%
Feb 25-1.07%
Feb 25-1.15%
Feb 25-1.14%
Jan 25-1.15%
Jan 25-1.18%
Jan 25-1.1%
Jan 25-0.94%
Jan 25-0.89%
Dec 24-0.9%
Dec 24-1.04%
Dec 24-1.05%
Dec 24-1.05%
Nov 24-1.03%
Nov 24-1.04%
Nov 24-1.24%
Nov 24-1.2%
Nov 24-1.35%
Oct 24-1.38%
Price to Sales
1000000012000000140000001600000018000000med 11739311.83Jul 22Jul 22Jul 22Aug 22Aug 22
IPX Price to Sales by quarter
PeriodPrice to Sales
Aug 2215865124.33
Aug 2215953141.67
Aug 2216063163.33
Aug 2211024171
Jul 2211486262
Jul 2210720511.2
Jul 2210298028
Jul 2211002166.67
Jul 2211992361.67
Jun 2213394257.74
Price to Book
05101520med 7.13Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IPX Price to Book by quarter
PeriodPrice to Book
Sep 260.56
Sep 260.58
Sep 260.68
Aug 260.65
Aug 260.7
Aug 260.73
Aug 260.78
Jul 260.64
Jul 260.67
Jul 260.71
Jul 260.78
Jul 260.89
Jun 260.82
Jun 260.96
Jun 261.12
Jun 261.09
May 261.29
May 261.17
May 261.12
May 261.28
May 261.04
Apr 260.91
Apr 261.02
Apr 260.99
Apr 260.85
Mar 260.72
Mar 260.72
Mar 261.08
Mar 261.46
Feb 261.51
Feb 261.31
Feb 261.27
Feb 261.34
Jan 261.55
Jan 2619.15
Jan 2614.92
Jan 2613.95
Jan 2612.72
Dec 2511.77
Dec 2510.54
Dec 2511.37
Dec 2510.82
Nov 2510.77
Nov 259.27
Nov 2510.89
Nov 2511.63
Oct 2513.98
Oct 2515.83
Oct 2516.27
Oct 2513.92
Oct 2514.15
Sep 2513.01
Sep 2510.79
Sep 2511.43
Sep 2512.44
Aug 2511.36
Aug 2510.73
Aug 2510.67
Aug 259.65
Aug 259.69
Jul 2510.32
Jul 258.69
Jul 258.44
Jul 257.7
Jun 257.87
Jun 257.07
Jun 256.66
Jun 257.19
May 256.2
May 256.05
May 255.43
May 255.88
May 255.62
Apr 255.44
Apr 255.07
Apr 253.75
Apr 253.64
Mar 254.64
Mar 255.18
Mar 255.33
Mar 255.27
Feb 256.08
Feb 2512.3
Feb 2511.43
Feb 2511.55
Jan 2511.48
Jan 2511.18
Jan 2511.99
Jan 2513.94
Jan 2514.73
Dec 2414.58
Dec 2412.62
Dec 2412.5
Dec 2412.58
Nov 2412.8
Nov 2412.71
Nov 2410.57
Nov 2410.99
Nov 249.79
Oct 249.57
IperionX Limited
IPX
Stockpicker

Video analysis: IPX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: IPX

IperionX Secures Second U.S. Army Task Order to Accelerate Industrial-Scale American Titanium Production

globenewswire.com · 31 Aug 2026

IperionX Secures Second U.S. Army Task Order to Accelerate Industrial-Scale American Titanium Production

SOUTH BOSTON, Va., Aug. 31, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) IperionX Limited announces that the U.S. Army has awarded Task Order 2 under the Small Business Innovation Research (SBIR) Phase III Indefinite Delivery, Indefinite Quantity (IDIQ) contract for Low-Cost, Domestic Titanium for Defense Applications.

IPX1031 Named Best Overall 1031 Exchange Company by Fit Small Business for Fifth Consecutive Year

globenewswire.com · 27 Aug 2026

IPX1031 Named Best Overall 1031 Exchange Company by Fit Small Business for Fifth Consecutive Year

CHICAGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Investment Property Exchange Services, Inc. (IPX1031), the national leader in 1031 Qualified Intermediary services, has again been recognized as the Best Overall 1031 Exchange Company by Fit Small Business, marking the fifth consecutive year (2022-2026) the company has received this distinction. In its 2026 review, Fit Small Business evaluated 1031 Exchange companies based on factors including nationwide coverage, exchange capabilities, insurance protection for exchange funds, educational resources, fees and customer reviews.

IPX Investors Have Opportunity to Join IperionX Limited Fraud Investigation with SBS Law

businesswire.com · 17 Aug 2026

IPX Investors Have Opportunity to Join IperionX Limited Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $IPX--IPX Investors Have Opportunity to Join IperionX Limited Fraud Investigation with SBS Law.

IperionX: The Qualification Stack Is Becoming A Strategic Moat

seekingalpha.com · 14 Aug 2026

IperionX: The Qualification Stack Is Becoming A Strategic Moat

IperionX offers a compelling bullish case due to domestic titanium scarcity, strategic government support, and the Titan Critical Minerals Project's robust economics. IPX's integrated qualification stack—from titanium powder to components—enhances platform value, with customer validation and government funding distinguishing it from typical pre-revenue peers. Operational risks remain, as sustained furnace reliability and continuous titanium powder production are not yet routine, despite 24/7 operations and recent capacity expansions.

IperionX Limited (IPX) Shareholder/Analyst Call Transcript

seekingalpha.com · 4 Aug 2026

IperionX Limited (IPX) Shareholder/Analyst Call Transcript

IperionX Limited (IPX) Shareholder/Analyst Call Transcript

IperionX Targets 200-Ton Titanium Run Rate as U.S. Supply Chain Takes Shape

marketbeat.com · 4 Aug 2026

IperionX Targets 200-Ton Titanium Run Rate as U.S. Supply Chain Takes Shape

IperionX NASDAQ: IPX is ramping commercial titanium production in Virginia while advancing its Tennessee mineral assets as part of a strategy to build a U.S. supply chain for titanium and other critical minerals, Founder and Chief Executive Officer Anastasios “Taso” Arima said in a company update.

IperionX Advances American Titanium Growth Strategy With Proposed U.S. Redomiciliation and Board Appointment

globenewswire.com · 3 Aug 2026

IperionX Advances American Titanium Growth Strategy With Proposed U.S. Redomiciliation and Board Appointment

Highlights  Proposed U.S. redomiciliation: IperionX intends to redomicile its ultimate parent company to Texas, subject to shareholder, court, regulatory and other customary approvals, to align the Company's legal and capital-markets structure with its integrated U.S. manufacturing, critical minerals and technology operations. Simplified Nasdaq structure: Subject to final structuring and exchange approvals, common stock in the new U.S. parent is expected to be listed directly on Nasdaq, replacing IperionX's existing ADS structure.

IperionX Webinar – Investor Update

globenewswire.com · 31 Jul 2026

IperionX Webinar – Investor Update

SOUTH BOSTON, Va., July 31, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (NASDAQ: IPX, ASX: IPX) (IperionX) is pleased to invite shareholders and investors to a webinar on Wednesday, August 5, 2026 at 8:00 am Australian Eastern Standard Time / Tuesday, August 4, 2026 at 18:00 pm U.S. Eastern Daylight Time , where Founder and CEO, Taso Arima will provide a company update.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.